Skip to content

Short Post-surgical Antibiotic Therapy in Spine Infections - a Prospective, Randomized, Unblinded, Non-inferiority Trial

Short Post-surgical Antibiotic Therapy in Spine Infections - a Pro-spective, Randomized, Unblinded, Non-inferiority Trial

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04048304
Enrollment
236
Registered
2019-08-07
Start date
2019-07-31
Completion date
2025-12-31
Last updated
2025-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infection

Brief summary

We implement a prospective, randomized, unblinded, non-inferiority trial regarding the duration of systemic, targeted antibiotic therapy after the first surgical debridement for spine infection; randomizing 1:1 between 1. Six and twelve weeks of antibiotic therapy if there is an implant left in place 2. Three and six weeks of antibiotic therapy if there is no implant left

Interventions

DRUGduration of standard antibiotic therapy

antibiotic therapy for spine infections. 3 vs 6 weeks if no implant left in place. 6 vs 12 weeks if implant left in place. The antibiotic agents used are officially indicated for orthopedic infections, including spine infections and available in Switzerland since decades. Standard dosing will be applied and only modified according to the patient's co-morbidities, intolerances and weight.

Sponsors

Balgrist University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

1:1 randomization

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Spine surgery and intraoperative debridement with any technique * At least 12 months of scheduled follow-up from hospitalization * Bacterial spine infection of any nature, independently of implants or co-morbidities

Exclusion criteria

* Mycobacterial, fungal, nocardial, and Actinomyces infections in the spine * Non-resected cancer in the infection site * Bone marrow or recent solid organ transplant patient (Recent: \<5 years) * Any other infection in the patient requiring more than 6 weeks of antibiotic therapy * More than three intraoperative debridements performed for spine infection * Absence of at least one surgical intraoperative debridement of infection

Design outcomes

Primary

MeasureTime frameDescription
Remission of infection at 12 months after treatment12 months after treatmentno clinical and microbiological recurrences

Secondary

MeasureTime frameDescription
costsup to 12 monthstotal costs for treatment of infection
duration of sick leaveup to 12 monthsduration of sick leave for treatment of infection
length of hospital stayup to 12 monthsnumber of days of hospital stay

Countries

Switzerland

Contacts

Primary ContactIlker Uckay, PD Dr med
ilker.uckay@balgrist.ch+41 44 386 1111
Backup ContactMichael Betz, PD Dr med
michael.betz@balgrist.ch+41 44 386 1111

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 28, 2026